Advertisement
Screener

INFUSYSTEM HOLDINGS, INC (INFU) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

INFUSYSTEM HOLDINGS, INC Increase (Decrease) in Accounts Receivable

INFUSYSTEM HOLDINGS, INC (INFU) reported Increase (Decrease) in Accounts Receivable of $5.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04

  • INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $3.44M.
  • INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $2.25M, a 7.40% increase year-over-year.
  • INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$2.43M.
  • INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $78.00K, a 46.21% decline year-over-year.
  • INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts receivable for fiscal 2025 was -$263.00K, a 137.52% decline from fiscal 2024.
  • INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts receivable for fiscal 2024 was $701.00K, a 70.33% decline from fiscal 2023.
  • INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts receivable for fiscal 2023 was $2.36M, a 104.94% increase from fiscal 2022.
  • INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts receivable for fiscal 2022 was $1.15M.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 monthIncrease (Decrease) in Accounts Receivable 12 month as first filed
2026-06-30$3.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$5.69M
10-Q · filed 2026-08-04
$3.26M
derived: sum of 3 quarters · filed 2026-08-04
$3.34M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$2.25M
10-Q · filed 2026-05-08
-$180.00K
derived: sum of 2 quarters · filed 2026-05-08
-$102.00K
derived: sum of 3 quarters · filed 2026-05-08
-$108.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$2.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$2.35M
derived: sum of 2 quarters · filed 2026-02-27
-$2.36M
derived: sum of 3 quarters · filed 2026-08-04
-$263.00K
10-K · filed 2026-02-27
2025-09-30$78.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$72.00K
derived: sum of 2 quarters · filed 2026-08-04
$2.17M
10-Q · filed 2025-11-04
$1.52M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$2.09M
10-Q · filed 2026-08-04
$1.44M
derived: sum of 3 quarters · filed 2026-08-04
$1.59M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$2.10M
10-Q · filed 2026-05-08
$1.45M
derived: sum of 2 quarters · filed 2026-05-08
$1.59M
derived: sum of 3 quarters · filed 2026-05-08
$2.56M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$647.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$502.00K
derived: sum of 2 quarters · filed 2026-02-27
$464.00K
derived: sum of 3 quarters · filed 2026-02-27
$701.00K
10-K · filed 2026-02-27
2024-09-30$145.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$1.11M
derived: sum of 2 quarters · filed 2025-11-04
$1.35M
10-Q · filed 2025-11-04
$2.68M
derived: sum of 4 quarters · filed 2025-11-04
2024-06-30$966.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$1.20M
10-Q · filed 2025-08-05
$2.53M
derived: sum of 3 quarters · filed 2025-08-05
$3.06M
derived: sum of 4 quarters · filed 2025-08-05
2024-03-31$237.00K
10-Q · filed 2025-05-08
$1.56M
derived: sum of 2 quarters · filed 2025-05-08
$2.09M
derived: sum of 3 quarters · filed 2025-05-08
$1.64M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$1.86M
derived: sum of 2 quarters · filed 2025-03-11
$1.40M
derived: sum of 3 quarters · filed 2025-03-11
$2.36M
10-K · filed 2025-03-11
2023-09-30$529.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$74.00K
derived: sum of 2 quarters · filed 2024-11-08
$1.03M
10-Q · filed 2024-11-08
$1.58M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30-$455.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$506.00K
10-Q · filed 2024-08-09
$1.05M
derived: sum of 3 quarters · filed 2024-08-09
$735.00K
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$961.00K
10-Q · filed 2024-05-09
$1.51M
derived: sum of 2 quarters · filed 2024-05-09
$1.19M
derived: sum of 3 quarters · filed 2024-05-09
$836.00K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$546.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10
$229.00K
derived: sum of 2 quarters · filed 2024-04-10
-$125.00K
derived: sum of 3 quarters · filed 2024-04-10
$1.15M
10-K · filed 2024-04-10
2022-09-30-$317.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$671.00K
derived: sum of 2 quarters · filed 2023-11-09
$607.00K
10-Q · filed 2023-11-09
-$5.00K
derived: sum of 4 quarters · filed 2024-04-10
2022-06-30-$354.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$924.00K
10-Q · filed 2023-08-09
$312.00K
derived: sum of 3 quarters · filed 2024-04-10
-$234.00K
derived: sum of 4 quarters · filed 2024-04-10
2022-03-31$1.28M
10-Q · filed 2023-05-09
$666.00K
derived: sum of 2 quarters · filed 2024-04-10
$120.00K
derived: sum of 3 quarters · filed 2024-04-10
$29.00K
derived: sum of 4 quarters · filed 2024-04-10
2021-12-31-$612.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10
-$1.16M
derived: sum of 2 quarters · filed 2024-04-10
-$1.25M
derived: sum of 3 quarters · filed 2024-04-10
-$829.00K
10-K · filed 2024-04-10
2021-09-30-$546.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$637.00K
derived: sum of 2 quarters · filed 2022-11-08
-$217.00K
10-Q · filed 2022-11-08
$924.00K
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30-$91.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$329.00K
10-Q · filed 2022-08-04
$1.47M
derived: sum of 3 quarters · filed 2023-03-16
$845.00K
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31$420.00K
10-Q · filed 2022-05-05
$1.56M
derived: sum of 2 quarters · filed 2023-03-16
$936.00K
derived: sum of 3 quarters · filed 2023-03-16
$1.42M
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$516.00K
derived: sum of 2 quarters · filed 2023-03-16
$1.00M
derived: sum of 3 quarters · filed 2023-03-16
$2.63M
10-K · filed 2023-03-16
2020-09-30-$625.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$138.00K
derived: sum of 2 quarters · filed 2021-11-15
$1.49M
10-Q · filed 2021-11-15
$2.31M
derived: sum of 4 quarters · filed 2022-03-15
2020-06-30$487.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$2.12M
10-Q · filed 2021-08-12
$2.94M
derived: sum of 3 quarters · filed 2022-03-15
$3.03M
derived: sum of 4 quarters · filed 2022-03-15
2020-03-31$1.63M
10-Q · filed 2021-05-10
$2.45M
derived: sum of 2 quarters · filed 2022-03-15
$2.54M
derived: sum of 3 quarters · filed 2022-03-15
2019-12-31$825.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$917.00K
derived: sum of 2 quarters · filed 2022-03-15
$1.56M
10-K · filed 2022-03-15
2019-09-30$92.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
$735.00K
10-Q · filed 2020-11-13
2019-06-30$643.00K
10-Q · filed 2020-08-14
2018-12-31-$1.91M
10-K · filed 2020-03-30
$4.41M
10-K · filed 2019-03-22
2017-12-31$5.34M
10-K · filed 2019-03-22
$5.45M
10-K · filed 2018-03-19
2016-12-31$4.59M
10-K · filed 2018-03-19
2015-12-31$7.56M
10-K · filed 2017-03-22
$9.14M
10-K · filed 2016-03-09
2014-12-31$5.38M
10-K/A · filed 2016-12-12
2013-12-31$8.72M
10-K · filed 2015-03-09
2012-12-31$3.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11
$4.04M
derived: sum of 2 quarters · filed 2014-03-11
$4.37M
derived: sum of 3 quarters · filed 2014-03-11
$6.49M
10-K · filed 2014-03-11
2012-09-30$857.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
$1.18M
derived: sum of 2 quarters · filed 2012-11-14
$3.30M
10-Q · filed 2012-11-14
$3.38M
derived: sum of 4 quarters · filed 2013-03-28
2012-06-30$324.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$2.45M
10-Q · filed 2012-08-08
$2.53M
derived: sum of 3 quarters · filed 2013-03-28
$4.67M
derived: sum of 4 quarters · filed 2013-03-28
2012-03-31$2.12M
10-Q · filed 2012-05-21
$2.20M
derived: sum of 2 quarters · filed 2013-03-28
$4.34M
derived: sum of 3 quarters · filed 2013-03-28
$4.94M
derived: sum of 4 quarters · filed 2013-03-28
2011-12-31$82.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
$2.22M
derived: sum of 2 quarters · filed 2013-03-28
$2.82M
derived: sum of 3 quarters · filed 2013-03-28
$4.42M
10-K · filed 2013-03-28
$4.87M
10-K · filed 2012-03-16
2011-09-30$2.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
$2.74M
derived: sum of 2 quarters · filed 2012-11-14
$4.34M
10-Q · filed 2012-11-14
$4.73M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$598.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$2.20M
10-Q · filed 2012-08-08
$2.59M
derived: sum of 3 quarters · filed 2012-08-08
$3.46M
derived: sum of 4 quarters · filed 2012-08-08
2011-03-31$1.60M
10-Q · filed 2012-05-21
$1.99M
derived: sum of 2 quarters · filed 2012-05-21
$2.87M
derived: sum of 3 quarters · filed 2012-05-21
2010-12-31$392.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16
$1.27M
derived: sum of 2 quarters · filed 2012-03-16
$3.95M
10-K · filed 2012-03-16
2010-09-30$874.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$3.56M
10-Q · filed 2011-11-14
2010-06-30$2.68M
10-Q · filed 2011-08-15
2009-12-31$5.36M
10-K · filed 2012-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
PRO DEX INC (PDEX)United States$0.234B13.64
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Profound Medical Corp. (PROF)$0.206B-7.37